Navigation Links
Domino/Aronberg Prescription Drug Validation Plan Saves Lives, Protects Privacy, Costs Less
Date:3/24/2009

TALLAHASSEE, Fla., March 24 /PRNewswire/ -- Florida's failure to adopt an effective prescription drug validation system has resulted in the loss of thousands of lives. But bipartisan legislation pending in the Legislature would bury Florida's costly crisis of rampant prescription drug fraud and doctor shopping.

"It is time to stop Floridians from dying from illegally obtained prescription drugs," said Rep. Carl Domino, a Jupiter Republican and sponsor of House Bill 143. "New technology is less costly, protects consumer privacy, and is in real time and cannot be defeated by a false identification."

HB 143 and Senate Bill 614, sponsored by Sen. Dave Aronberg, a Greenacres Democrat, clamp down on fraud and abuse by requiring an innovative but simple-to-use system that would simultaneously protect patients, prescribing pharmacists and health-care professionals, and Florida taxpayers.

The two lawmakers, along with other proponents of their bills came together in the Florida Capitol to discuss how their bills will save lives and money while carefully protecting citizens' privacy rights.

The Domino/Aronberg bills require dispensers to use inexpensive biometric scanning devices -- fingerprints or retinal scans, for example -- to biologically identify people attempting to fill prescriptions for Class II, III or IV controlled substances. These include such powerful painkillers as Vicodin and OxyContin, which law enforcement officials say have become the prescription drugs of choice among teenagers in search of a high.

Too often, however, prescription drug abuse leads to tragedy. In the first half of 2008 alone, the drug oxycodone was involved in more than 10 percent of all 4,055 drug-related deaths in Florida, according to the Florida Medical Examiners Commission.

"As an assistant attorney general, I investigated the marketing and abuse of controlled substances and saw firsthand the consequences of not having a prescription-drug validation system in place," Sen. Aronberg said. "Ours is not a record that Florida can be proud of, but the legislation that Rep. Domino and I propose would fix this problem and save lives."

When the prescribed system is in place, a Florida Department of Health database will assign a unique identification number to the biometric scan, which will then immediately convey the information back to the prescriber. Names of patients, Social Security numbers and other personal information will never be transmitted to the database.

The unique ID number gives the pharmacist or dispensing health-care professional the ability to immediately determine whether the prescription conflicts or overlaps with other medication delivered to the same person. This also protects pharmacists and doctors from becoming innocent victims of fraud. Moreover, it reduces their legal liability by enabling them to quickly recognize prescriptions that pose an interaction hazard.

Dr. Fred Lippman, of the Nova Southeastern University Health Professions Division in Fort Lauderdale, endorses the Domino/Aronberg proposal for another reason: It protects patients who chronically suffer with severe pain, e.g. cancer patients, and rely on their prescriptions to get through the day.

"Pharmaceutical manufacturers produce a limited supply of pain medications. When legally controlled medications are illegally diverted, the adequate supply for legitimate use is placed at risk," said Lippman, a pharmacist who served in the Florida House of Representatives from 1978 to 1998.

Unlike competing bills addressing the same problem, the Domino/Aronberg plan's costs would largely be absorbed by industry, federal grants and dispensers. Start-up cost for dispensers is estimated at an on average cost of $350. Monthly operational costs are projected to run from $50 to $150, but could be offset by incentives and credits.

A competing bill requires that all costs incurred by the state -- that is, taxpayers -- be reimbursed through federal grants and private funding. In difficult economic times, that's a risky revenue stream.

Fourteen South Florida pharmacies currently are part of a successful pilot program being offered through Bio-Tech Medical Software, Inc. to aid efforts to combat doctor shopping and prescription drug abuse in Broward and Palm Beach counties.

"If everybody - the doctors and pharmacists - were in sync they would have not filled my son's prescriptions and he would be alive. This is not just about me losing my son. It's bigger than that. It is about preventing other families from going through what I went through," said Linda McCalister, a Fort Lauderdale mother whose son died as a result of prescription drug abuse. "There needs to be more regulation of controlled substances. Other states have these databases, and there is no reason we shouldn't have one here."

Contact: Ryan Banfill

(850) 222-1996


'/>"/>
SOURCE Bio-Tech Medical Software, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. FDA Updates Prescription Guidelines for Blood Thinner
2. University of Texas Study Details Lengthy Payment Delays for Medicare Part D Prescription Drug Claims, Confirming Need for Legislative Fix
3. Prescription labels geared toward pharmacies, not patients
4. AUDIO from Medialink and Pfizer: Prescription for Safer Drugs Discussed in Washington
5. Medicare Prescription Drug Benefit, Nonprofit Hospitals, Ambulatory Surgery Centers, Statistical Methods, and Pay-For-Performance Highlighted In the Latest INQUIRY Journal
6. Governor Rendell Appoints Members of Chronic Care Commission as Part of Prescription for PA
7. AUDIO from Medialink and Pfizer: A New Prescription for Safer Drugs
8. Class Settlement Could Result in Considerable Savings for Certain Consumers of Prescription Pharmaceuticals
9. New Survey Finds Strong Public Interest in Prescription Drug Safety Issues
10. Audio: New Survey Finds Strong Public Interest in Prescription Drug Safety Issues
11. New Pharmacys Owners Go Beyond Your Prescription
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/10/2016)... ... February 10, 2016 , ... Intalere’s 2016 Executive Forum, taking ... of the country’s top healthcare executives to share insights on transformational strategies to ... Forum is the provider-centric perspective, experience, expertise and strategy shared by the participants,” ...
(Date:2/10/2016)... MA (PRWEB) , ... February 10, 2016 , ... Gout ... switch, and brings pain that is often severe, with intense swelling and redness. It ... than eight million people, but older adults are the most susceptible, according to the ...
(Date:2/10/2016)... ... ... Armune BioScience signed a definitive agreement with ARCpoint Labs ... country. Launched in April of 2015, Apifiny is the only cancer specific, non-PSA blood ... exceeded 3,000 tests in 2015. Primary care physicians and urologists have utilized Apifiny to ...
(Date:2/10/2016)... ... February 10, 2016 , ... Pediatric ... in their patients. Research shows that the Goal Attainment Scale (GAS) captures 20% ... this challenge and learn more about the Goal Attainment Scale, Education Resources Inc. ...
(Date:2/10/2016)... ... February 10, 2016 , ... A ... Safety Congress and Expo event March 9-11, 2016. Hosted by Ohio's Bureau of ... , As the longest running and largest worker's compensation event in Ohio, ...
Breaking Medicine News(10 mins):
(Date:2/10/2016)... LONDON , February 10, 2016 ... 2016, which will be held at Victoria Park Plaza in ... host an informative seminar on technology and future advances for ... seminar, led by Lorna Graham , associate director of ... technology to keep up with new regulations and standards in ...
(Date:2/10/2016)... ATLANTA , Feb. 10, 2016  LexisNexis® ... and technology, today announced the launch of ... analytics solution that helps improve and optimize the ... evaluation of performance using severity-adjusted scores. By measuring ... a critical solution to deliver better outcomes, improve ...
(Date:2/10/2016)... SAN DIEGO , Feb. 10, 2016 ... biopharmaceutical company developing novel, clinical-stage therapies for sickle cell ... an underwritten public offering of 29,090,910 units at a ... unit consists of one share of the Company,s common ... the Company,s common stock at an exercise price of ...
Breaking Medicine Technology: